Clinical Trial Update: Safety and Efficacy of Cariprazine in Patients With Schizophrenia [Phase 3]

View source ↗

Summary

Phase 3 trial update on safety and efficacy of cariprazine in schizophrenia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• cariprazine (cariprazine)

Snippet

Sponsor: Forest Laboratories | Conditions: Schizophrenia | Phase 3 | Status: COMPLETED | Results posted: 2018-10-29